Synonyms: AAI101 | OCID-5090
enmetazobactam is an approved drug (FDA (2024))
Compound class:
Synthetic organic
Comment: Enmetazobactam is an extended-spectrum β-lactamase inhibitor. It is an N-methylated tazobactam derivative. It is intended for use alongside β-lactamase antimicrobials, to reduce their degradation.
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2024)) |
IUPAC Name |
(2S,3S,5R)-3-methyl-3-[(3-methyltriazol-3-ium-1-yl)methyl]-4,4,7-trioxo-4λ6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate |
International Nonproprietary Names | |
INN number | INN |
10913 | enmetazobactam |
Synonyms |
AAI101 | OCID-5090 |
Database Links | |
Specialist databases | |
Antibiotic DB | Enmetazobactam, AAI101, OCID 5090 |
Other databases | |
CAS Registry No. | 1001404-83-6 (source: Scifinder) |
ChEMBL Ligand | CHEMBL4458276 |
GtoPdb PubChem SID | 472319310 |
PubChem CID | 23653540 |
Search Google for chemical match using the InChIKey | HFZITXBUTWITPT-YWVKMMECSA-N |
Search Google for chemicals with the same backbone | HFZITXBUTWITPT |
Search PubMed clinical trials | enmetazobactam |
Search PubMed titles | enmetazobactam |
Search PubMed titles/abstracts | enmetazobactam |
UniChem Compound Search for chemical match using the InChIKey | HFZITXBUTWITPT-YWVKMMECSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | HFZITXBUTWITPT-YWVKMMECSA-N |